Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician.

Published

Journal Article (Review)

Patients with prosthetic heart valves require chronic oral anticoagulation. In this clinical scenario, physicians must be mindful of the thromboembolic and bleeding risks related to chronic anticoagulant therapy. Currently, only vitamin K antagonists are approved for this indication. This paper reviews the main heart valve guidelines focusing on the use of oral anticoagulation in these patients.

Full Text

Duke Authors

Cited Authors

  • Leiria, TLL; Lopes, RD; Williams, JB; Katz, JN; Kalil, RAK; Alexander, JH

Published Date

  • May 2011

Published In

Volume / Issue

  • 31 / 4

Start / End Page

  • 514 - 522

PubMed ID

  • 21327503

Pubmed Central ID

  • 21327503

Electronic International Standard Serial Number (EISSN)

  • 1573-742X

Digital Object Identifier (DOI)

  • 10.1007/s11239-011-0574-9

Language

  • eng

Conference Location

  • Netherlands